Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
Internal Medicine Meeting 2020 canceled due to COVID-19 concerns
ACP announced March 10 that it had canceled Internal Medicine Meeting 2020, which was scheduled for April 23-25 in Los Angeles.
ACP's decision was based on recent reports from the World Health Organization (WHO) and the CDC regarding novel coronavirus disease (COVID-19) and in recognition of the vital role of internists in diagnosing, managing, and caring for their patients and communities on the front lines. Considering these factors, ACP felt the only responsible choice was to cancel. ACP also recognized its professional responsibility to consider the safety of its meeting participants by modeling social distancing and not contributing to the spread of the virus through a large public gathering.
“Internists are at the forefront of patient care, and we are committed to supporting their primary responsibility of delivering high-quality care,” said ACP President Robert McLean, MD, MACP. “ACP is also committed to ensuring the health and safety of our meeting participants, in support of our mission, to enhance the quality and effectiveness of health care by fostering excellence and professionalism in the practice of medicine.”
ACP members and other meeting participants will be offered a refund. More information and details are available. ACP's COVID-19 Resource Hub, which includes updated information like ACP's “Novel Coronavirus: A Physician's Guide,” is available.
New highlighting feature added to MKSAP 18 Digital and Complete versions
MKSAP 18 Digital and Complete now have highlighting capabilities in three distinct colors: yellow, green, and pink. Users can highlight text or questions by clicking on the highlighting icon at the bottom of the screen and review highlights using the highlight index.
MKSAP 18 Digital and Complete also feature apps (available for iOS and Android devices) for learners to work online or offline. Learners can create unlimited custom quizzes, refer to peer statistics, and view related text and questions.
Developed by an editorial team of more than 200 physicians, MKSAP 18 includes 11 medical knowledge sections and 1,200 multiple-choice questions. It is available in Print, Digital, and Complete formats. MKSAP 18 Complete includes MKSAP 18 Print, MKSAP 18 Digital with ongoing text updates and bonus questions, Board Basics® (in print and e-book), digital flashcards, and Virtual Dx.
More information about MKSAP 18 is available.
Explore new content, enhanced search functionality on ACP's Online Learning Center
ACP's Online Learning Center now features an enhanced search functionality that allows queries by format, product, or clinical topic. The Online Learning Center is a centralized gateway to more than 350 online learning activities, many of which are free to members and all of which are CME and MOC eligible. Recent topics include coronavirus, human trafficking, and opioid risk management.
ICYMI: Highlights from ACP Internist Weekly
Mammography may not benefit healthy women older than age 75. Researchers used Medicare data to examine continuing annual mammography after a certain age or ceasing to screen. Among 1,058,013 women, 1,533 breast cancer deaths occurred during follow-up with the former strategy and 1,304 occurred with the latter. The estimated difference in risk for breast cancer between continuing and stopping screening over eight years was −1.0 death per 1,000 women for ages 70 to 74 years and 0.07 death per 1,000 women for ages 75 to 84 years. The study was published Feb. 25 by Annals of Internal Medicine and was summarized in the Feb. 25 ACP Internist Weekly.
No tests, medications recommended for acute cough with suspected acute bronchitis in immunocompetent adults. The CHEST Expert Cough Panel recommended against routine tests and routine use of antibiotics, antiviral therapy, antitussives, inhaled beta-agonists, inhaled anticholinergics, inhaled corticosteroids, oral corticosteroids, oral NSAIDs, or other therapies until research supporting their use becomes available. If acute bronchitis persists or worsens, reassessment and targeted investigation can be considered, and in worsening cases where a complicating bacterial infection is suspected, antibiotics can be considered, the panel said. The recommendations were ungraded consensus statements due to the lack of available evidence, prompting the panel to call for additional research. The panel's report was published Feb. 21 by CHEST and was summarized in the March 3 ACP Internist Weekly.
ACP Internist Weekly is an e-newsletter published on Tuesdays and available online. Subscribe online.
